FDA Drug Application (010533) for PBZ-SR by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number010533
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePBZ-SR
Active IngredientTRIPELENNAMINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TRIPELENNAMINE HYDROCHLORIDE3


Back to FDA Applications sponsored by NOVARTIS